Veracyte Inc (NASDAQ: VCYT) closed the day trading at $23.62 up 0.25% from the previous closing price of $23.56. In other words, the price has increased by $+0.06 from its previous closing price. On the day, 902026 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of VCYT, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 46.36. For the most recent quarter (mrq), Quick Ratio is recorded 4.40 and its Current Ratio is at 4.66. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on February 23, 2024, Reiterated its Buy rating but revised its target price to $33 from $30 previously.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $33.Scotiabank initiated its Sector Outperform rating on January 05, 2023, with a $33 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 19 when JONES EVAN/ FA sold 3,090 shares for $30.17 per share. The transaction valued at 93,232 led to the insider holds 35,173 shares of the business.
JONES EVAN/ FA sold 838 shares of VCYT for $25,257 on Jul 19. The Director now owns 37,601 shares after completing the transaction at $30.14 per share. On Jul 18, another insider, BISHOP JOHN L, who serves as the Director of the company, sold 10,000 shares for $30.50 each. As a result, the insider received 305,000 and left with 33,125 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VCYT now has a Market Capitalization of 1.73B and an Enterprise Value of 1.52B. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.95 while its Price-to-Book (P/B) ratio in mrq is 1.64. Its current Enterprise Value per Revenue stands at 4.21 whereas that against EBITDA is 156.17.
Stock Price History:
Over the past 52 weeks, VCYT has reached a high of $30.52, while it has fallen to a 52-week low of $19.52. The 50-Day Moving Average of the stock is 26.27, while the 200-Day Moving Average is calculated to be 25.20.
Shares Statistics:
Over the past 3-months, VCYT traded about 602.97K shares per day on average, while over the past 10 days, VCYT traded about 764.22k shares per day. A total of 75.74M shares are outstanding, with a floating share count of 74.77M. Insiders hold about 1.28% of the company’s shares, while institutions hold 98.64% stake in the company. Shares short for VCYT as of Jan 31, 2024 were 2.46M with a Short Ratio of 4.08, compared to 2.51M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 3.37% and a Short% of Float of 3.82%.
Earnings Estimates
Current recommendations for the stock of the company come from 5 analysts. On average, analysts expect EPS of -$0.15 for the current quarter, with a high estimate of -$0.09 and a low estimate of -$0.18, while EPS last year was -$0.11. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.2 and -$0.32 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.01, with 6 analysts recommending between $0.33 and -$0.28.
Revenue Estimates
8 analysts predict $93.37M in revenue for the current quarter. It ranges from a high estimate of $95.66M to a low estimate of $91.2M. As of the current estimate, Veracyte Inc’s year-ago sales were $75.81M, an estimated increase of 23.20% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $98.75M, an increase of 9.30% less than the figure of $23.20% in the same quarter last year. There is a high estimate of $101.45M for the next quarter, whereas the lowest estimate is $97.2M.
A total of 9 analysts have provided revenue estimates for VCYT’s current fiscal year. The highest revenue estimate was $400.67M, while the lowest revenue estimate was $387.74M, resulting in an average revenue estimate of $396.67M. In the same quarter a year ago, actual revenue was $361.05M, up 9.90% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $442.36M in the next fiscal year. The high estimate is $451.22M and the low estimate is $432.9M. The average revenue growth estimate for next year is up 11.50% from the average revenue estimate for this year.
